Kura Oncology Inc’s recently made public that its Director Hasnain Faheem unloaded Company’s shares for reported $0.18 million on Mar 21 ’25. In the deal valued at $8.00 per share,22,682 shares were sold. As a result of this transaction, Hasnain Faheem now holds 23,983 shares worth roughly $0.14 million.
Then, FAHEEM HASNAIN bought 30,000 shares, generating $235,500 in total proceeds.
Before that, DOYLE THOMAS JAMES sold 4,949 shares. Kura Oncology Inc shares valued at $38,958 were divested by the SVP, Finance & Accounting at a price of $7.87 per share. As a result of the transaction, DOYLE THOMAS JAMES now holds 88,193 shares, worth roughly $0.53 million.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 3.08% to $6.03. Over the last five days, the stock has gained 7.30%. Kura Oncology Inc shares have fallen nearly -30.77% since the year began. Nevertheless, the stocks have fallen -69.05% over the past one year. While a 52-week high of $23.48 was reached on 02/05/25, a 52-week low of $5.41 was recorded on 04/07/25. SMA at 50 days reached $7.38, while 200 days put it at $13.86.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 5.82, which if violated will result in even more drops to 5.62. On the upside, there is a resistance level at 6.17. A further resistance level may holdings at 6.32. The Relative Strength Index (RSI) on the 14-day chart is 39.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.49%. Stochastics %K at 24.06% indicates the stock is a holding.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-03-31, dropping by -0.41 million shares to a total of 8.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 9.21 million shares. There was a decline of -4.65%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
